The current practice regarding neuro-prognostication for comatose children after cardiac arrest differs between and

Maayke Hunfeld1, Marlie A C Muusers2, Coriene E Catsman2

  • 1Department of Paediatric Neurology, Erasmus MC, Sophia Children's Hospital, Dr Molewaterplein 40, Rotterdam, the Netherlands; Intensive Care and Department of Paediatric Surgery, Erasmus MC, Sophia Children's Hospital, Dr Molewaterplein 40, Rotterdam, the Netherlands.

Insights

Neuro-prognostication guidelines for comatose children after cardiac arrest (CA) are rare in European PICUs. Current practices vary, highlighting the need for standardized, evidence-based international guidelines to ensure accurate patient assessment and care.

Area of Science:

  • Pediatric Intensive Care Medicine
  • Pediatric Neurology
  • Clinical Neurophysiology

Background:

  • Neuro-prognostication in comatose children following cardiac arrest (CA) is critical for guiding clinical decisions.
  • Current practices in European Paediatric Intensive Care Units (PICUs) for neuro-prognostication after CA are not well-defined.
  • Lack of standardized guidelines may lead to inconsistencies in patient management and outcome assessment.

Purpose of the Study:

  • To describe current neuro-prognostication practices in European PICUs for comatose children after CA.
  • To identify the methods and timing used for neurological assessment and prognosis determination.
  • To understand the approaches to patient management once a poor neurological outcome is suspected or determined.

Main Methods:

  • An anonymous online survey was distributed to members of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC) and the European Paediatric Neurology Society (EPNS).
  • The survey included 49 questions covering general information, CA, neuro-prognostication, and follow-up.
  • Data were collected from respondents across 23 countries, representing 45 PICUs.

Main Results:

  • Only 20% of participating PICUs had a local neuro-prognostication guideline.
  • Neurological examination (92%), MRI (82%), and continuous EEG (cEEG) (45%) were the most utilized methods for assessing neurological outcome.
  • Decisions regarding withdrawing life-sustaining therapy (WLST) varied, with 55% considering it an option for futile prognoses, while 44% continued treatment.

Conclusions:

  • There is a significant lack of local guidelines for neuro-prognostication in pediatric CA survivors across Europe.
  • Variability in assessment methods and outcome interpretation necessitates the development of international, evidence-based guidelines.
  • Inaccurate prognostication can lead to premature WLST, potentially impacting research and patient outcomes, underscoring the need for standardized protocols.
Abstract